aTyr Pharma reported $2.42M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Ardelyx USD 127.27M 7.15M Mar/2026
aTyr Pharma USD 2.42M 83.19M Mar/2026
Biogen USD 1.96B 69.6M Mar/2026
Bristol-Myers Squibb USD 20.07B 11.77B Mar/2026
Cipla INR 59.27B 1.71B Mar/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.19M 96K Mar/2026
CSL USD 5.7B 2.82B Dec/2025
Curis USD 9.02M 23.01M Dec/2025
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
Grifols EUR 1.99B 217.4M Dec/2025
Lakefront Biotherapeutics EUR 70.18M 50.08M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
United Therapeutics USD 5.9B 5.1B Mar/2026
Xoma USD 22.84M 1.67M Sep/2024